Literature DB >> 32350425

Risk factor for Alzheimer's disease breaks the blood-brain barrier.

Makoto Ishii, Costantino Iadecola.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Neurodegeneration

Mesh：

Substances：

Year:  2020        PMID： 32350425      PMCID： PMC8018585          DOI： 10.1038/d41586-020-01152-8

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  8 in total

1.  Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

Authors:  Robert D Bell; Ethan A Winkler; Itender Singh; Abhay P Sagare; Rashid Deane; Zhenhua Wu; David M Holtzman; Christer Betsholtz; Annika Armulik; Jan Sallstrom; Bradford C Berk; Berislav V Zlokovic
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

2.  Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.

Authors:  Mario Merlini; Victoria A Rafalski; Pamela E Rios Coronado; T Michael Gill; Maya Ellisman; Gayathri Muthukumar; Keshav S Subramanian; Jae Kyu Ryu; Catriona A Syme; Dimitrios Davalos; William W Seeley; Lennart Mucke; Robert B Nelson; Katerina Akassoglou
Journal:  Neuron       Date:  2019-02-05       Impact factor: 17.173

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 4.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

5.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.

Authors:  Kenzo Koizumi; Yorito Hattori; Sung Ji Ahn; Izaskun Buendia; Antonio Ciacciarelli; Ken Uekawa; Gang Wang; Abigail Hiller; Lingzhi Zhao; Henning U Voss; Steven M Paul; Chris Schaffer; Laibaik Park; Costantino Iadecola
Journal:  Nat Commun       Date:  2018-09-19       Impact factor: 14.919

Review 6.  Alzheimer's Disease and Vascular Aging: JACC Focus Seminar.

Authors:  Marta Cortes-Canteli; Costantino Iadecola
Journal:  J Am Coll Cardiol       Date:  2020-03-03       Impact factor: 24.094

7.  Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.

Authors:  Daniel A Nation; Melanie D Sweeney; Axel Montagne; Abhay P Sagare; Lina M D'Orazio; Maricarmen Pachicano; Farshid Sepehrband; Amy R Nelson; David P Buennagel; Michael G Harrington; Tammie L S Benzinger; Anne M Fagan; John M Ringman; Lon S Schneider; John C Morris; Helena C Chui; Meng Law; Arthur W Toga; Berislav V Zlokovic
Journal:  Nat Med       Date:  2019-01-14       Impact factor: 53.440

8.  The blood-brain barrier in health and disease: Important unanswered questions.

Authors:  Caterina P Profaci; Roeben N Munji; Robert S Pulido; Richard Daneman
Journal:  J Exp Med       Date:  2020-04-06       Impact factor: 14.307
  8 in total
  8 in total

1.  High-Dose Acetaminophen Alters the Integrity of the Blood-Brain Barrier and Leads to Increased CNS Uptake of Codeine in Rats.

Authors:  Junzhi Yang; Robert D Betterton; Erica I Williams; Joshua A Stanton; Elizabeth S Reddell; Chidinma E Ogbonnaya; Emma Dorn; Thomas P Davis; Jeffrey J Lochhead; Patrick T Ronaldson
Journal:  Pharmaceutics       Date:  2022-04-27       Impact factor: 6.525

Review 2.  The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases.

Authors:  Xin Zang; Si Chen; JunYao Zhu; Junwen Ma; Yongzhen Zhai
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

Review 3.  Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications.

Authors:  Miren Altuna; Gonzalo Olmedo-Saura; María Carmona-Iragui; Juan Fortea
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

4.  TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p/NFATC3 in Aβ-microenvironment.

Authors:  Hao Ning; Lu Zhang; Baicheng Zhu; Xinxin Zhou; Tianyuan Zhang; Teng Ma
Journal:  Cell Death Dis       Date:  2022-05-13       Impact factor: 9.685

Review 5.  Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis.

Authors:  Ruiqing Ni
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

6.  Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.

Authors:  Rebecca Parodi-Rullán; Jorge Ghiso; Erwin Cabrera; Agueda Rostagno; Silvia Fossati
Journal:  Aging Cell       Date:  2020-11-06       Impact factor: 9.304

7.  Brain region-specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer's disease.

Authors:  Madhurima Dey; Frank J Gunn-Moore; Bettina Platt; Terry K Smith
Journal:  Lipids Health Dis       Date:  2020-08-31       Impact factor: 3.876

8.  ApoE and immunity in Alzheimer's disease and related tauopathies: Low-density lipoprotein receptor to the rescue.

Authors:  Andrew S Mendiola; Reshmi Tognatta; Zhaoqi Yan; Katerina Akassoglou
Journal:  Neuron       Date:  2021-08-04       Impact factor: 18.688
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.